Form 8-K - Current report:
SEC Accession No. 0001193125-21-003641
Filing Date
2021-01-07
Accepted
2021-01-07 06:16:01
Documents
14
Period of Report
2021-01-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d281965d8k.htm   iXBRL 8-K 26377
2 EX-99.1 d281965dex991.htm EX-99.1 101552
6 GRAPHIC g281965g0107072404599.jpg GRAPHIC 5199
  Complete submission text file 0001193125-21-003641.txt   280605

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amrn-20210107.xsd EX-101.SCH 3074
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20210107_lab.xml EX-101.LAB 18838
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20210107_pre.xml EX-101.PRE 11841
7 EXTRACTED XBRL INSTANCE DOCUMENT d281965d8k_htm.xml XML 3941
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 21512943
SIC: 2834 Pharmaceutical Preparations